Literature DB >> 11889079

Attenuated acute liver injury in mice by naked hepatocyte growth factor gene transfer into skeletal muscle with electroporation.

F Xue1, T Takahara, Y Yata, M Minemura, C Y Morioka, S Takahara, E Yamato, K Dono, A Watanabe.   

Abstract

BACKGROUND: Hepatocyte growth factor (HGF) plays an essential role in hepatic development and regeneration, and shows proliferative and antiapoptotic activity in hepatocytes. AIMS: To establish an effective new method for HGF gene transfer in vivo and to investigate its effects in acute experimental liver injury. ANIMALS: Eight week old female mice were used.
METHODS: Rat HGF gene in a modified pKSCX plasmid was transferred to the tibialis anterior muscle by electroporation using a pulse generator. Four days later, plasma HGF concentrations were determined by enzyme linked immunosorbent assay every two days for three weeks. To confirm the efficacy of electroporation, a plasmid bearing green fluorescence protein (GFP) was transferred similarly. Four days after electroporation, carbon tetrachloride (CCl(4)) was administered to mice to induce acute liver injury. Plasma alanine aminotransferase (ALT) activity was measured. Hepatic apoptosis was assessed by Hoechst 33258 staining and the TUNEL method.
RESULTS: Fluorescence microscopy showed strong green fluorescence where the GFP gene had been transferred into muscle. In mice given the HGF gene, HGF in plasma was increased up to fourfold from pretreatment amounts, peaking 6-9 days after electroporation and quickly decreasing within three weeks. Compared with the group without HGF transfer, the percentage of apoptotic hepatocytes after CCl(4) intoxication was significantly lower, as was ALT activity. In addition, ALT activity normalised more rapidly in the HGF gene transfer group.
CONCLUSIONS: Naked DNA injection and transfer by electroporation efficiently brings about HGF expression in vivo, which can attenuate acute liver injury.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11889079      PMCID: PMC1773169          DOI: 10.1136/gut.50.4.558

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  40 in total

1.  Insertional mutagenesis of AAV2 capsid and the production of recombinant virus.

Authors:  J E Rabinowitz; W Xiao; R J Samulski
Journal:  Virology       Date:  1999-12-20       Impact factor: 3.616

2.  Enhancement of gene transfer efficiency into human cancer cells by modification of retroviral vectors and addition of chemicals.

Authors:  J J Song; J H Kim; H Lee; E Kim; J Kim; Y S Park; J Ahn; N C Yoo; J K Roh; B S Kim
Journal:  Oncol Rep       Date:  2000 Jan-Feb       Impact factor: 3.906

Review 3.  The hepatocyte growth factor/Met pathway in development, tumorigenesis, and B-cell differentiation.

Authors:  R van der Voort; T E Taher; P W Derksen; M Spaargaren; R van der Neut; S T Pals
Journal:  Adv Cancer Res       Date:  2000       Impact factor: 6.242

4.  Unique epithelial cell production of hepatocyte growth factor/scatter factor by putative precancerous intestinal metaplasias and associated "intestinal-type" biliary cancer chemically induced in rat liver.

Authors:  G H Lai; S Radaeva; T Nakamura; A E Sirica
Journal:  Hepatology       Date:  2000-06       Impact factor: 17.425

5.  In vivo transfer of hepatocyte growth factor gene accelerates proliferation of hepatic oval cells in a 2-acetylaminofluorene/partial hepatectomy model in rats.

Authors:  G Shiota; T Kunisada; K Oyama; A Udagawa; T Nomi; K Tanaka; A Tsutsumi; M Isono; T Nakamura; H Hamada; T Sakatani; S Sell; K Sato; H Ito; H Kawasaki
Journal:  FEBS Lett       Date:  2000-03-31       Impact factor: 4.124

6.  Attenuated liver fibrosis and depressed serum albumin levels in carbon tetrachloride-treated IL-6-deficient mice.

Authors:  M Natsume; H Tsuji; A Harada; M Akiyama; T Yano; H Ishikura; I Nakanishi; K Matsushima; S Kaneko; N Mukaida
Journal:  J Leukoc Biol       Date:  1999-10       Impact factor: 4.962

7.  Quantitative assessment of retroviral transfer of the human multidrug resistance 1 gene to human mobilized peripheral blood progenitor cells engrafted in nonobese diabetic/severe combined immunodeficient mice.

Authors:  B Schiedlmeier; K Kühlcke; H G Eckert; C Baum; W J Zeller; S Fruehauf
Journal:  Blood       Date:  2000-02-15       Impact factor: 22.113

8.  Elevation of serum hepatocyte growth factor concentration in patients with gastric cancer is mediated by production from tumor tissue.

Authors:  K Beppu; A Uchiyama; T Morisaki; K Nakamura; H Noshiro; K Matsumoto; T Nakamura; M Tanaka; M Katano
Journal:  Anticancer Res       Date:  2000 Mar-Apr       Impact factor: 2.480

9.  In vivo retrovirus-mediated gene transfer to the liver of dogs results in transient expression and induction of a cytotoxic immune response.

Authors:  A Izembart; E Aguado; O Gauthier; D Aubert; P Moullier; N Ferry
Journal:  Hum Gene Ther       Date:  1999-12-10       Impact factor: 5.695

10.  Protective action of hepatocyte growth factor for acute liver injury caused by D-galactosamine in transgenic mice.

Authors:  J Okano; G Shiota; H Kawasaki
Journal:  Hepatology       Date:  1997-11       Impact factor: 17.425

View more
  8 in total

1.  Hepatocyte growth factor gene therapy prevents radiation-induced liver damage.

Authors:  Chau-Hua Chi; I-Li Liu; Wei-Yu Lo; Bor-Song Liaw; Yu-Shan Wang; Kwan-Hwa Chi
Journal:  World J Gastroenterol       Date:  2005-03-14       Impact factor: 5.742

2.  Using reconfigurable microfluidics to study the role of HGF in autocrine and paracrine signaling of hepatocytes.

Authors:  Dipali Patel; Amranul Haque; Yandong Gao; Alexander Revzin
Journal:  Integr Biol (Camb)       Date:  2015-07       Impact factor: 2.192

3.  Effects of electroporation on primary rat hepatocytes in vitro.

Authors:  Yun-Qing Yao; Ding-Feng Zhang; Ai-Long Huang; Yun Luo; Da-Zhi Zhang; Bo Wang; Wei-Ping Zhou; Hong Ren; Shu-Hua Guo
Journal:  World J Gastroenterol       Date:  2002-10       Impact factor: 5.742

4.  A Mesenchymal-Epithelial Transition Factor-Agonistic Antibody Accelerates Cirrhotic Liver Regeneration and Improves Mouse Survival Following Partial Hepatectomy.

Authors:  Kuai Ma; Weitao Que; Xin Hu; Wen-Zhi Guo; Er-Li Gu; Liang Zhong; Virginia Morello; Manuela Cazzanti; Paolo Michieli; Terumi Takahara; Xiao-Kang Li
Journal:  Liver Transpl       Date:  2021-10-12       Impact factor: 6.112

5.  Autocrine expression of hepatocyte growth factor and its cytoprotective effect on hepatocyte poisoning.

Authors:  Yong He; Jun Zhou; Ke-Feng Dou; Yong Chen; Qing-Guo Yan; Hai-Min Li
Journal:  World J Gastroenterol       Date:  2004-10-01       Impact factor: 5.742

6.  Hepatocyte growth factor gene therapy accelerates regeneration in cirrhotic mouse livers after hepatectomy.

Authors:  F Xue; T Takahara; Y Yata; Y Kuwabara; E Shinno; K Nonome; M Minemura; S Takahara; X Li; E Yamato; A Watanabe
Journal:  Gut       Date:  2003-05       Impact factor: 23.059

7.  A synthetic biology-based device prevents liver injury in mice.

Authors:  Peng Bai; Haifeng Ye; Mingqi Xie; Pratik Saxena; Henryk Zulewski; Ghislaine Charpin-El Hamri; Valentin Djonov; Martin Fussenegger
Journal:  J Hepatol       Date:  2016-04-09       Impact factor: 25.083

8.  Skeletal muscle targeting in vivo electroporation-mediated HGF gene therapy of bleomycin-induced pulmonary fibrosis in mice.

Authors:  Yukio Umeda; Tsutomu Marui; Yukihiro Matsuno; Koyo Shirahashi; Hisashi Iwata; Hisato Takagi; Kunio Matsumoto; Toshikazu Nakamura; Atsushi Kosugi; Yoshio Mori; Hirofumi Takemura
Journal:  Lab Invest       Date:  2004-07       Impact factor: 5.662

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.